WO2010105454A1 - Adenosine triphosphate intercalated hydrotalcite film and preparation method therefor - Google Patents

Adenosine triphosphate intercalated hydrotalcite film and preparation method therefor Download PDF

Info

Publication number
WO2010105454A1
WO2010105454A1 PCT/CN2009/072079 CN2009072079W WO2010105454A1 WO 2010105454 A1 WO2010105454 A1 WO 2010105454A1 CN 2009072079 W CN2009072079 W CN 2009072079W WO 2010105454 A1 WO2010105454 A1 WO 2010105454A1
Authority
WO
WIPO (PCT)
Prior art keywords
adenosine triphosphate
film
hydrotalcite
solution
atp
Prior art date
Application number
PCT/CN2009/072079
Other languages
French (fr)
Chinese (zh)
Inventor
卫敏
倪学云
靳兰
段雪
Original Assignee
北京化工大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 北京化工大学 filed Critical 北京化工大学
Publication of WO2010105454A1 publication Critical patent/WO2010105454A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C26/00Coating not provided for in groups C23C2/00 - C23C24/00
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C28/00Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D
    • C23C28/04Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D only coatings of inorganic non-metallic material
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C8/00Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals
    • C23C8/80After-treatment
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D11/00Electrolytic coating by surface reaction, i.e. forming conversion layers
    • C25D11/02Anodisation
    • C25D11/04Anodisation of aluminium or alloys based thereon
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D11/00Electrolytic coating by surface reaction, i.e. forming conversion layers
    • C25D11/02Anodisation
    • C25D11/04Anodisation of aluminium or alloys based thereon
    • C25D11/18After-treatment, e.g. pore-sealing

Definitions

  • the invention belongs to the technical field of bio-inorganic composite materials, in particular to a vertical abasic growth adenosine triphosphate intercalated hydrotalcite film and a preparation method thereof.
  • Background technique :
  • LDHs Layered Double Hydroxides
  • an anionic layered inorganic functional material as a high performance catalytic material, adsorbent material, separation material, functional additive material, biomaterial and Pharmaceutical materials are used in many industries of the national economy. Due to the problems of easy loss and difficult recycling of LDHs powder in practical applications, the emergence of LDHs membranes has attracted more and more attention. Previously, LDHs films prepared by solvent evaporation, layer-layer assembly and in-situ growth methods have been easy to recycle and improve the properties of materials.
  • Duan Xue et al. used in-situ synthesis technology to anodize the surface of the substrate by using the surface anodized aluminum sheet as the substrate.
  • Aluminum provides the aluminum source needed for the growth of hydrotalcite.
  • the pH of the reaction solution is adjusted by adding ammonia water, so that the Ni 2+ ions and NH 3 in the solution grow under the near neutral condition, and the density is controlled to be perpendicular to the substrate growth.
  • a nickel-aluminum nitrate hydrotalcite (NiAl-LDHs) film was found to have superhydrophobic properties.
  • Adenosine triphosphate can be used as an injection reagent for clinical use in heart failure, myocarditis, myocardial infarction, cerebral arteriosclerosis, coronary arteriosclerosis, acute polio, progressive muscular atrophy, and the like.
  • the rate of absorption of the agent needs to be controlled during the injection to avoid potential hazards such as dizziness, head swelling, chest tightness and hypotension.
  • the object of the present invention is to provide a vertical abasic growth adenosine triphosphate intercalated hydrotalcite film and a preparation method thereof.
  • the adenosine triphosphate (ATP) intercalated hydrotalcite film is a supramolecular structure, and its crystal structure maintains the crystal structure of the hydrotalcite material. Its chemical formula is:
  • M 2+ represents a divalent metal cation, for example, selected from the group consisting of Zn 2+ , Mg 2+ , Co 2+ , Ni 2+ , Ca 2+ , Cu 2+ , Fe 2+ , and Mn 2+ .
  • M 3+ represents a trivalent metal cation, and one of Al 3+ , Cr 3+ , Ga 3+ , In 3+ , Co 3+ , Fe 3+ , and V 3+ is selected
  • said M 2+ represents Zn 2+ , Co 2+ or Ni 2+
  • said M 3+ represents Al 3+ .
  • the ATP 3 _ represents an anion of adenosine triphosphate.
  • the present invention employs an in situ growth technique to form an adenosine triphosphate intercalated hydrotalcite film material having a laminate aligned perpendicular to the anodized alumina substrate on an anodized alumina substrate.
  • the specific preparation steps of the present invention are as follows:
  • the amount of the divalent metal salt contained per 150 ml of the reaction synthetic liquid is 0.005-0.06 mol, and the amount of the NH 4 N0 3 substance is 0.005-0.09 mol; preferably every 150 ml of the described
  • the amount of the divalent metal salt contained in the reaction synthesis liquid is 0.01-0.06 mol, and the amount of the NH 4 N0 3 substance is 0.01-0.06 mol; more preferably, every 150 ml of the reaction synthetic liquid is contained
  • the amount of the substance of the divalent metal salt is 0.015-0.03 mol, the amount of the substance of NH 4 N0 3 is 0.03-0.06 mol; the mass fraction of the aqueous ammonia may be 1%-5%, preferably 1%-4%, more preferably 2%-3% ;
  • adenosine triphosphate solution Dissolving adenosine triphosphate in water to obtain adenosine triphosphate solution, adjusting the pH of the adenosine triphosphate solution to between 5.9 and 8.5, and then placing the aluminum sheet with hydrotalcite film prepared in step b at 40-130 ° C
  • the reaction was carried out at a temperature of 12-96 h. After the reaction, the product was taken out, rinsed with deionized water for 3-5 times, and dried at room temperature to obtain a film of adenosine triphosphate intercalated hydrotalcite.
  • the concentration of the adenosine triphosphate solution is 0.5-2 g/L, preferably 1-2 g/L, and the mass fraction of ammonia water is 1% to 5%, preferably 1% to 4%, more preferably 2 %-3%.
  • the invention has the advantages that: by using the in situ growth technology, the adenosine triphosphate is inserted between the hydrotalcite layers to realize the immobilization of the adenosine triphosphate to achieve the sustained release of the target drug.
  • BRIEF DESCRIPTION OF THE DRAWINGS: 1 is an X-ray powder diffraction pattern of an adenosine triphosphate intercalated hydrotalcite film on an anodized aluminum substrate prepared in Example 1.
  • Fig. 2 is a scanning electron microscope top view of the adenosine triphosphate intercalated hydrotalcite film prepared in Example 1.
  • Figure 3 is a scanning electron micrograph of the adenosine triphosphate intercalated hydrotalcite film prepared in Example 1.
  • Step A The aluminum piece was cut into pieces of lO cmxlO cm, ultrasonically cleaned in absolute ethanol and deionized water for 3 min, then placed in 0.1 M NaOH solution for 2 min, then rinsed with deionized water.
  • the cleaned aluminum piece is used as the anode
  • the lead piece is used as the cathode
  • the 1 M 3 ⁇ 4S0 4 solution is used as the electrolyte, and electrolysis is performed under constant pressure.
  • the working voltage is 20 V
  • the current is 2 A
  • the electrolysis time is 1 h.
  • the electrolysis temperature is room temperature, thereby forming an anodized aluminum layer on the surface of the metal aluminum, and the obtained anodized aluminum/aluminum (AAO/A1) substrate is washed with a large amount of deionized water, and dried at 70 ° C for use;
  • Step B Weigh 2.960 g of Zn(N0 3 ) 2 ⁇ 6H 2 O (0.01 mol) and 4.8 g of NH 4 NO 3 (0.06 mol), respectively, in deionized water to prepare 150 ml of the reaction synthesis solution, and then use 13 ⁇ 4 ⁇ 3 ⁇ 40 at a concentration of 1% adjusts the pH of the reaction synthesis solution to 6.5, and vertically hangs the anodized aluminum/aluminum substrate of the size 1 cm ⁇ 2 cm prepared in the step A in the above reaction synthesis solution at 75 ° C Counter After 48 h, after the reaction, rinse with deionized water for 3 times, and dry at room temperature to obtain an aluminum sheet with a hydrotalcite film;
  • Step C Weigh 0.1 g of adenosine triphosphate dissolved in deionized water to prepare 150 ml of adenosine triphosphate solution, and then adjust the pH of the adenosine triphosphate solution to 6.5 with a concentration of 1% ⁇ 3 ⁇ H 2 0.
  • the aluminum piece of the hydrotalcite film was suspended vertically in the above reaction synthesis solution, and reacted at 75 ° C for 48 h. After the reaction, it was washed 5 times with deionized water and dried at room temperature to obtain a film of adenosine triphosphate intercalated hydrotalcite.
  • the adenosine triphosphate intercalated hydrotalcite film prepared by in-situ growth method has a layer spacing of 1.640 ⁇ ; indicating that adenosine triphosphate successfully enters the hydrotalcite film layer. It can be seen from the plane and cross-sectional photographs of the scanning electron microscope that in the film, the hydrotalcite laminate is arranged perpendicular to the substrate, and the thickness of the film is about 0.45 ⁇ .
  • Procedure ⁇ An anodized aluminum/aluminum substrate was obtained by the procedure of Example 1 in the procedure of Example 1.
  • Step B Weigh 2.932 g of Co(N0 3 ) 2 ⁇ 6H 2 O (0.01 mol) and 4.8 g of NH 4 NO 3 ⁇ ; 0.06 moi:) dissolved in deionized water to prepare 150 ml of the reaction synthesis solution.
  • the pH of the reaction mixture was adjusted to 6.5 by using ⁇ 3 ⁇ H 2 0 at a concentration of 1%.
  • the anodized aluminum/aluminum (AAO/A1) substrate having a size of 1 cm ⁇ 2 cm prepared in the step A was vertically suspended in the above reaction synthesis solution, and reacted at 75 ° C for 48 h. After the completion of the reaction, the mixture was taken out, rinsed with deionized water, and dried at room temperature to obtain an aluminum sheet having a hydrotalcite film.
  • Step C Weigh 0.15 g of adenosine triphosphate dissolved in deionized water to prepare 150 ml of adenosine triphosphate solution, and adjust the pH of the adenosine triphosphate solution to 6.5 with a concentration of 1% ⁇ 3 ⁇ H 2 0.
  • the aluminum sheet with the hydrotalcite film is suspended vertically in the above reaction synthesis solution, and reacted at 75 ° C for 48 h. After the reaction, it is washed 5 times with deionized water and dried at room temperature to obtain adenosine triphosphate intercalated hydrotalcite. film.
  • the adenosine triphosphate intercalated hydrotalcite film prepared by in-situ growth method has a plate spacing of 1.656 nm; indicating that adenosine triphosphate successfully enters the hydrotalcite film layer. It can be seen from the plane and cross-sectional photographs of the scanning electron microscope that in the film, the hydrotalcite laminate is arranged perpendicular to the substrate, and the thickness of the film is about 0.45 ⁇ .
  • Step ⁇ The AAO/A1 substrate was obtained by the procedure of Example 1 in Example 1.
  • Step B Weigh 2.908 g of Ni(N0 3 ) 2 ⁇ 6H 2 O (0.01 mol) and 4.8 g of NH 4 N0 3 (0.06 mol), respectively, in deionized water to prepare 100 ml of the reaction synthesis solution, and then The pH of the reaction mixture was adjusted to 6.5 with a concentration of 1% ⁇ 3 ⁇ 3 ⁇ 40.
  • the anodized aluminum/aluminum (AAO/A1) substrate having a size of 1 cm ⁇ 2 cm prepared in the step A was vertically suspended in the above reaction synthesis solution, and reacted at 75 ° C for 48 hours. After the completion of the reaction, the mixture was taken out, rinsed with deionized water, and dried at room temperature to obtain an aluminum sheet having a hydrotalcite film.
  • Step C Weigh 0.15 g of adenosine triphosphate dissolved in deionized water to prepare 150 ml of adenosine triphosphate solution, and adjust the pH of the adenosine triphosphate solution to 6.5 with a concentration of 1% ⁇ 3 ⁇ H 2 0.
  • the aluminum sheet with hydrotalcite film is suspended vertically in the above reaction synthesis solution, and reacted at 75 ° C for 48 h. After the reaction, it is washed 5 times with deionized water and dried at room temperature to obtain a film of adenosine triphosphate intercalated hydrotalcite. .
  • the adenosine triphosphate intercalated hydrotalcite film prepared by in-situ growth method has a plate spacing of 1.635 nm; indicating that adenosine triphosphate successfully enters the hydrotalcite film layer. It can be seen from the plane and cross-sectional photographs of the scanning electron microscope that in the film, the hydrotalcite laminate is arranged perpendicular to the substrate, and the thickness of the film is about 0.45 ⁇ .

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Metallurgy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Cardiology (AREA)
  • Mechanical Engineering (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Electrochemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to the technical field of biological-inorganic composites, and discloses an adenosine triphosphate (ATP) intercalated hydrotalcite film grown perpendicular to a substrate and a preparation method therefor. The invention uses an in-situ growth method to produce a hydrotalcite film to which ATP is then added. The specific steps are: first, forming an anodic aluminium oxide layer on the surface of a metallic aluminium, then producing a hydrotalcite film; next, immersing the hydrotalcite film into an ATP solution and drying it at room temperature to obtain an ATP intercalated hydrotalcite film. The advantages of the invention are that ATP is intercalated into the interlayer of hydrotalcite by applying an in-situ growth technique; this immobilizes the ATP, and achieves the slow release of target medicine by utilizing the interlayer confinement effect of hydrotalcite.

Description

一种三磷酸腺苷插层水滑石薄膜及其制备方法  Adenosine triphosphate intercalated hydrotalcite film and preparation method thereof
技术领域: Technical field:
本发明属于生物一无机复合材料技术领域,特别涉及一种垂直基底生长 的三磷酸腺苷插层水滑石薄膜及其制备方法。 背景技术:  The invention belongs to the technical field of bio-inorganic composite materials, in particular to a vertical abasic growth adenosine triphosphate intercalated hydrotalcite film and a preparation method thereof. Background technique:
层状双羟基复合金属氧化物 (Layered Double Hydroxides, LDHs), 是一 类阴离子型层状无机功能材料, 它作为高性能的催化材料、 吸附材料、 分离 材料、 功能性助剂材料、 生物材料和医药材料等应用于国民经济诸多行业。 由于 LDHs粉体在实际应用中存在的易流失、 难回收等问题, LDHs膜的出现 引起了人们更广泛的关注。 前人曾采用溶剂蒸发法, 层 -层组装法和原位生 长法等制备的 LDHs膜既便于回收再利用又有利于提高材料的性能。  Layered Double Hydroxides (LDHs), an anionic layered inorganic functional material, as a high performance catalytic material, adsorbent material, separation material, functional additive material, biomaterial and Pharmaceutical materials are used in many industries of the national economy. Due to the problems of easy loss and difficult recycling of LDHs powder in practical applications, the emergence of LDHs membranes has attracted more and more attention. Previously, LDHs films prepared by solvent evaporation, layer-layer assembly and in-situ growth methods have been easy to recycle and improve the properties of materials.
在文献 (1) J. Am. Chem. Soc, 2006, 128: 4872-4880中, Takayoshi Sasaki 等人首先将 Co-Al水滑石剥层, 然后用层 -层组装法得到了水滑石层板与阴 离子高聚物交替排列的水滑石薄膜, 为制备水滑石薄膜提供了新的方法。  In the literature (1) J. Am. Chem. Soc, 2006, 128: 4872-4880, Takayoshi Sasaki et al first stripped Co-Al hydrotalcite and then obtained the hydrotalcite laminate with layer-layer assembly method. A hydrotalcite film in which anionic polymers are alternately arranged provides a new method for preparing hydrotalcite films.
在文献 (2) Adv. Mater., 2006, 18: 3089-3093中, 段雪等人采用原位合成技 术, 以经表面阳极氧化后的铝片为基片, 利用基片表面上的阳极氧化铝提供 水滑石生长所需的铝源,通过滴加氨水调节反应溶液的 pH值,使溶液中 Ni2+ 离子与 NH3在接近中性条件下生长出疏密可控的垂直于基片生长的镍铝硝 酸根水滑石 (NiAl-LDHs)薄膜, 并发现该薄膜具有超疏水的性能。 In the literature (2) Adv. Mater., 2006, 18: 3089-3093, Duan Xue et al. used in-situ synthesis technology to anodize the surface of the substrate by using the surface anodized aluminum sheet as the substrate. Aluminum provides the aluminum source needed for the growth of hydrotalcite. The pH of the reaction solution is adjusted by adding ammonia water, so that the Ni 2+ ions and NH 3 in the solution grow under the near neutral condition, and the density is controlled to be perpendicular to the substrate growth. A nickel-aluminum nitrate hydrotalcite (NiAl-LDHs) film was found to have superhydrophobic properties.
在文献 (3) Chem. Mater., 2004, 16: 3774-3779中, Duk- Young Jung等人采 用溶剂蒸发技术以单晶硅为基底制备了层板平行于基底方向排列的水滑石 薄膜。作者认为水滑石成膜后可明显于粉体研究水滑石在离子交换反应中形 貌以及层间距的变化情况。 目前还没有任何关于药物分子插层水滑石的记载。而本发明的发明人发 现, 通过将药物分子插层在水滑石层间可以使得水滑石层板的优势 (例如, 层间限域作用) 得以发挥。 In the literature (3) Chem. Mater., 2004, 16: 3774-3779, Duk-Young Jung et al. used a solvent evaporation technique to prepare a hydrotalcite film in which the layers were aligned parallel to the substrate direction on the basis of single crystal silicon. The authors believe that the morphology of the hydrotalcite in the ion exchange reaction and the variation of the interlayer spacing can be studied obviously after the hydrotalcite is formed into a film. There is currently no record of intercalated hydrotalcites for drug molecules. The inventors of the present invention have found that the advantage of hydrotalcite laminates (e.g., interlayer confinement) can be exploited by intercalating drug molecules between hydrotalcite layers.
三磷酸腺苷可以作为一种注射试剂, 临床上现用于心力衰竭、 心肌炎、 心肌梗塞、 脑动脉硬化、 冠状动脉硬化、 急性脊髓灰质炎、 进行性肌萎缩性 疾患等。 在注射过程中需要控制该试剂的吸收速度来避免引发头暈、 头胀、 胸闷及低血压等潜在的危险。 通过将三磷酸腺苷插入水滑石层间, 利用水滑 石的层间限域作用可以达到缓释目标药物的目的。 发明内容:  Adenosine triphosphate can be used as an injection reagent for clinical use in heart failure, myocarditis, myocardial infarction, cerebral arteriosclerosis, coronary arteriosclerosis, acute polio, progressive muscular atrophy, and the like. The rate of absorption of the agent needs to be controlled during the injection to avoid potential hazards such as dizziness, head swelling, chest tightness and hypotension. By inserting adenosine triphosphate into the hydrotalcite layer, the purpose of the sustained release of the target drug can be achieved by utilizing the interlaminar restriction of hydrotalcite. Summary of the invention:
本发明目的在于提供一种垂直基底生长的三磷酸腺苷插层水滑石薄膜 及其制备方法。 三磷酸腺苷 (ATP)插层水滑石薄膜为超分子结构, 其晶体结 构保持了水滑石材料的晶体结构, 其化学式为:  The object of the present invention is to provide a vertical abasic growth adenosine triphosphate intercalated hydrotalcite film and a preparation method thereof. The adenosine triphosphate (ATP) intercalated hydrotalcite film is a supramolecular structure, and its crystal structure maintains the crystal structure of the hydrotalcite material. Its chemical formula is:
[(M2+)1-x(M3+)x(OH )2]x+(ATP3-)x/3 - m¾0 , 其中, 0·2 χ 0·33, m 为层 间结晶水分子数, 且 m=3-6。 [(M 2+ ) 1-x (M 3+ ) x (OH ) 2 ] x+ (ATP 3 -) x/3 - m3⁄40 , where 0·2 χ 0·33, m is the number of crystal water molecules in the layer , and m = 3-6.
更具体地说, M2+表示二价金属阳离子,例如,为选自 Zn2+、 Mg2+、 Co2+、 Ni2+、 Ca2+、 Cu2+、 Fe2+和 Mn2+中的一种或几种, M3+表示三价金属阳离子, 为选择 Al3+、 Cr3+、 Ga3+、 In3+、 Co3+、 Fe3+和 V3+中的一种或几种, 优选地, 所述 M2+表示 Zn2+、 Co2+或 Ni2+, 所述 M3+表示 Al3+More specifically, M 2+ represents a divalent metal cation, for example, selected from the group consisting of Zn 2+ , Mg 2+ , Co 2+ , Ni 2+ , Ca 2+ , Cu 2+ , Fe 2+ , and Mn 2+ . One or more of them, M 3+ represents a trivalent metal cation, and one of Al 3+ , Cr 3+ , Ga 3+ , In 3+ , Co 3+ , Fe 3+ , and V 3+ is selected Or several, preferably, said M 2+ represents Zn 2+ , Co 2+ or Ni 2+ , and said M 3+ represents Al 3+ .
所述 ATP3_表示三磷酸腺苷的阴离子。 The ATP 3 _ represents an anion of adenosine triphosphate.
本发明采用原位生长技术,在阳极氧化铝基底上形成了层板垂直于阳极 氧化铝基底排列的三磷酸腺苷插层水滑石薄膜材料。本发明的具体制备步骤 如下:  The present invention employs an in situ growth technique to form an adenosine triphosphate intercalated hydrotalcite film material having a laminate aligned perpendicular to the anodized alumina substrate on an anodized alumina substrate. The specific preparation steps of the present invention are as follows:
a. 将铝片分别在无水乙醇和去离子水中超声清洗 2-10 min, 然后放入 NaOH溶液中处理 1-3 min, 再用去离子水冲洗 3-5遍, 将清洗后的铝片作为 阳极, 铅片作为阴极, 以¾804溶液作电解液, 进行恒压电解, 工作电压为 15-25 V, 电流为 1.5-3 A, 电解时间为 0.5-2 h, 电解温度为室温, 在金属铝 的表面形成阳极氧化铝层, 得到阳极氧化铝 /铝基底, 在 25-90°C下干燥后备 用; 优选地, 所述 NaOH溶液的浓度为 0.1-0.4 M, 更优选为 0.1-0.3 M; 所 述 H2S04溶液的浓度为 0.5-2 M, 例如可以为 1-2 M, 优选为 0.5-1 M; a. Ultrasonic cleaning of aluminum flakes in anhydrous ethanol and deionized water for 2-10 min, then NaOH solution for 1-3 min, then rinsed with deionized water for 3-5 times, the cleaned aluminum flakes As Anode, lead sheet as cathode, 3⁄480 4 solution as electrolyte, constant voltage electrolysis, working voltage is 15-25 V, current is 1.5-3 A, electrolysis time is 0.5-2 h, electrolysis temperature is room temperature, in metal The surface of the aluminum forms an anodized aluminum layer to obtain an anodized aluminum/aluminum substrate, which is used after drying at 25-90 ° C. Preferably, the concentration of the NaOH solution is 0.1-0.4 M, more preferably 0.1-0.3 M. The concentration of the H 2 S0 4 solution is 0.5-2 M, for example, may be 1-2 M, preferably 0.5-1 M;
b. 分别称取二价金属盐和 NH4NO^§解于去离子水中配成反应合成液, 再用氨水调节反应合成液的 pH在 5.9-8.5之间, 将阳极氧化铝 /铝基底垂直 悬吊在上述反应合成液中, 在 40-130 °C温度下反应 12-96 h, 反应结束后取 出, 用去离子水冲洗 3-5遍, 于室温下干燥, 得到长有水滑石薄膜的铝片。 优选地, 每 150 ml 的所述反应合成液所含的二价金属盐的物质的量为 0.005-0.06 mol, NH4N03的物质的量为 0.005-0.09 mol; 优选每 150 ml的所 述反应合成液所含的二价金属盐的物质的量为 0.01-0.06 mol, NH4N03的物 质的量为 0.01-0.06 mol; 更优选地, 每 150 ml的所述反应合成液所含的二价 金属盐的物质的量为 0.015-0.03 mol, NH4N03的物质的量为 0.03-0.06 mol; 氨水的质量分数可以为 1%-5%, 优选为 1%-4%, 更优选为 2%-3%; b. Weigh the divalent metal salt and the NH 4 NO ^ § solution separately into deionized water to form a reaction synthesis liquid, and then adjust the pH of the reaction synthesis solution to 5.9-8.5 with ammonia water, and the anodized aluminum/aluminum substrate is vertical. Suspension in the above reaction synthesis solution, reaction at 40-130 ° C for 12-96 h, after the reaction is completed, rinsed with deionized water for 3-5 times, and dried at room temperature to obtain a hydrotalcite-like film. Aluminum sheet. Preferably, the amount of the divalent metal salt contained per 150 ml of the reaction synthetic liquid is 0.005-0.06 mol, and the amount of the NH 4 N0 3 substance is 0.005-0.09 mol; preferably every 150 ml of the described The amount of the divalent metal salt contained in the reaction synthesis liquid is 0.01-0.06 mol, and the amount of the NH 4 N0 3 substance is 0.01-0.06 mol; more preferably, every 150 ml of the reaction synthetic liquid is contained The amount of the substance of the divalent metal salt is 0.015-0.03 mol, the amount of the substance of NH 4 N0 3 is 0.03-0.06 mol; the mass fraction of the aqueous ammonia may be 1%-5%, preferably 1%-4%, more preferably 2%-3% ;
c 将三磷酸腺苷溶解在水中得到三磷酸腺苷溶液,将所述三磷酸腺苷溶 液的 pH值调节在 5.9-8.5之间,然后放入步骤 b中制得的长有水滑石薄膜的 铝片, 于 40-130 °C温度下反应 12-96 h, 反应结束后将产品取出, 用去离子 水冲洗 3-5遍, 于室温下干燥, 得到三磷酸腺苷插层水滑石的薄膜。 具体来 说, 所述三磷酸腺苷溶液的浓度为 0.5-2 g/L, 优选为 1-2 g/L, 氨水的质量分 数为 1%-5%, 优选为 1%-4%, 更优选为 2%-3%。  c Dissolving adenosine triphosphate in water to obtain adenosine triphosphate solution, adjusting the pH of the adenosine triphosphate solution to between 5.9 and 8.5, and then placing the aluminum sheet with hydrotalcite film prepared in step b at 40-130 ° C The reaction was carried out at a temperature of 12-96 h. After the reaction, the product was taken out, rinsed with deionized water for 3-5 times, and dried at room temperature to obtain a film of adenosine triphosphate intercalated hydrotalcite. Specifically, the concentration of the adenosine triphosphate solution is 0.5-2 g/L, preferably 1-2 g/L, and the mass fraction of ammonia water is 1% to 5%, preferably 1% to 4%, more preferably 2 %-3%.
本发明的优点在于: 利用原位生长技术, 实现了将三磷酸腺苷插入水滑 石层间, 实现三磷酸腺苷的固载化从而达到缓释目标药物的目的。 附图说明: 图 1为实施例 1制备的在阳极氧化铝基底上的三磷酸腺苷插层水滑石薄 膜的 X射线粉末衍射图。 The invention has the advantages that: by using the in situ growth technology, the adenosine triphosphate is inserted between the hydrotalcite layers to realize the immobilization of the adenosine triphosphate to achieve the sustained release of the target drug. BRIEF DESCRIPTION OF THE DRAWINGS: 1 is an X-ray powder diffraction pattern of an adenosine triphosphate intercalated hydrotalcite film on an anodized aluminum substrate prepared in Example 1.
图 2为实施例 1制备的三磷酸腺苷插层水滑石薄膜的扫描电镜俯视图。 图 3为实施例 1制备的三磷酸腺苷插层水滑石薄膜的扫描电镜截面图。  Fig. 2 is a scanning electron microscope top view of the adenosine triphosphate intercalated hydrotalcite film prepared in Example 1. Figure 3 is a scanning electron micrograph of the adenosine triphosphate intercalated hydrotalcite film prepared in Example 1.
具体实施方式: detailed description:
通过下面实施例对本发明予以具体说明。  The invention is specifically illustrated by the following examples.
在以下实施例中,使用如下方法测定各实施例中制得的根据本发明的产 口口:  In the following examples, the mouths according to the present invention prepared in the respective examples were measured using the following method:
以日本岛津 XRD-6000型 X射线衍射仪进行结构分析, Cu Ka光源(λ = 0.154 nm), 电压 40 Kv, 电流 30 mA, 连续扫描, 扫描速度 2 min。  The structure was analyzed by a Shimadzu XRD-6000 X-ray diffractometer, Cu Ka source (λ = 0.154 nm), voltage 40 Kv, current 30 mA, continuous scanning, scanning speed 2 min.
扫描电镜表征在 Hitachi S-4700型扫描电镜 (日本日立公司) 上进行。  Scanning electron microscopy characterization was performed on a Hitachi S-4700 scanning electron microscope (Hitachi, Japan).
实施例 1 Example 1
步骤 A: 将铝片剪切成 lO cmxlO cm的片, 在无水乙醇和去离子水中分 别进行超声清洗 3 min, 然后放入 0.1 M的 NaOH溶液中处理 2 min, 再用去 离子水冲洗干净,将清洗后的铝片作为阳极,铅片作为阴极,以 1 M的 ¾S04 溶液作电解液, 在恒压下进行电解, 工作电压为 20 V, 电流为 2 A, 电解时 间为 1 h, 电解温度为室温, 从而在金属铝的表面形成阳极氧化铝层, 将得 到的阳极氧化铝 /铝(AAO/A1)基底用大量去离子水清洗干净, 在 70 °C下干 燥后备用; Step A: The aluminum piece was cut into pieces of lO cmxlO cm, ultrasonically cleaned in absolute ethanol and deionized water for 3 min, then placed in 0.1 M NaOH solution for 2 min, then rinsed with deionized water. The cleaned aluminum piece is used as the anode, the lead piece is used as the cathode, and the 1 M 3⁄4S0 4 solution is used as the electrolyte, and electrolysis is performed under constant pressure. The working voltage is 20 V, the current is 2 A, and the electrolysis time is 1 h. The electrolysis temperature is room temperature, thereby forming an anodized aluminum layer on the surface of the metal aluminum, and the obtained anodized aluminum/aluminum (AAO/A1) substrate is washed with a large amount of deionized water, and dried at 70 ° C for use;
步骤 B : 分别称取 2.960 g 的 Zn(N03)2 · 6H2O(0.01mol)和 4.8 g 的 NH4NO3(0.06 mol)溶解于去离子水中配成 150 ml反应合成液, 再用浓度为 1%的 Ν¾ · ¾0将反应合成液的 pH调节为 6.5, 将步骤 A中制备的大小为 1 cmX2 cm阳极氧化铝 /铝基底垂直悬吊在上述反应合成液中, 在 75°C下反 应 48 h, 反应结束后用去离子水冲洗 3遍, 于室温下干燥, 得到长有水滑石 薄膜的铝片; Step B: Weigh 2.960 g of Zn(N0 3 ) 2 · 6H 2 O (0.01 mol) and 4.8 g of NH 4 NO 3 (0.06 mol), respectively, in deionized water to prepare 150 ml of the reaction synthesis solution, and then use 13⁄4 · 3⁄40 at a concentration of 1% adjusts the pH of the reaction synthesis solution to 6.5, and vertically hangs the anodized aluminum/aluminum substrate of the size 1 cm×2 cm prepared in the step A in the above reaction synthesis solution at 75 ° C Counter After 48 h, after the reaction, rinse with deionized water for 3 times, and dry at room temperature to obtain an aluminum sheet with a hydrotalcite film;
步骤 C:称取 0.1 g的三磷酸腺苷溶解于去离子水中配成 150 ml的三磷 酸腺苷溶液, 再用浓度 1%的 ΝΗ3 · H20将三磷酸腺苷溶液的 pH为 6.5, 将 步骤 B 中制备的长有水滑石薄膜的铝片垂直悬吊在上述反应合成液中, 在 75°C下反应 48 h, 反应结束后用去离子水冲洗 5遍, 于室温下干燥, 得到三 磷酸腺苷插层水滑石的薄膜。 Step C: Weigh 0.1 g of adenosine triphosphate dissolved in deionized water to prepare 150 ml of adenosine triphosphate solution, and then adjust the pH of the adenosine triphosphate solution to 6.5 with a concentration of 1% ΝΗ 3 · H 2 0. The aluminum piece of the hydrotalcite film was suspended vertically in the above reaction synthesis solution, and reacted at 75 ° C for 48 h. After the reaction, it was washed 5 times with deionized water and dried at room temperature to obtain a film of adenosine triphosphate intercalated hydrotalcite.
由 X射线衍射图可知, 采用原位生长法制备的三磷酸腺苷插层水滑石 薄膜, 其层板间距为 1.640 匪; 说明三磷酸腺苷成功进入水滑石膜层间。 从 扫描电镜的平面和截面照片中可以看出在该膜中, 水滑石层板为垂直于基底 的排列方式, 膜的厚度大约为 0.45 μηι。 实施例 2  It can be seen from the X-ray diffraction pattern that the adenosine triphosphate intercalated hydrotalcite film prepared by in-situ growth method has a layer spacing of 1.640 Å; indicating that adenosine triphosphate successfully enters the hydrotalcite film layer. It can be seen from the plane and cross-sectional photographs of the scanning electron microscope that in the film, the hydrotalcite laminate is arranged perpendicular to the substrate, and the thickness of the film is about 0.45 μη. Example 2
步骤 Α: 按实施例 1中步骤 Α方法得到阳极氧化铝 /铝基底。  Procedure Α: An anodized aluminum/aluminum substrate was obtained by the procedure of Example 1 in the procedure of Example 1.
步骤 B: 分别称取 2.932 g 的 Co(N03)2 · 6H2O(0.01 mol)和 4.8 g 的 NH4NO3 <;0.06 moi:)溶解于去离子水中配成 150 ml的反应合成液,再用浓度为 1%的 ΝΗ3 · H20将反应合成液的 pH调节为 6.5。 将步骤 A中制备的大小为 1 cmX2 cm阳极氧化铝 /铝 (; AAO/A1)基底垂直悬吊在上述反应合成液中, 在 75°C下反应 48 h。 反应结束后取出, 用去离子水冲洗后, 于室温下干燥, 得 到长有水滑石薄膜的铝片。 Step B: Weigh 2.932 g of Co(N0 3 ) 2 · 6H 2 O (0.01 mol) and 4.8 g of NH 4 NO 3 <; 0.06 moi:) dissolved in deionized water to prepare 150 ml of the reaction synthesis solution. The pH of the reaction mixture was adjusted to 6.5 by using ΝΗ 3 · H 2 0 at a concentration of 1%. The anodized aluminum/aluminum (AAO/A1) substrate having a size of 1 cm×2 cm prepared in the step A was vertically suspended in the above reaction synthesis solution, and reacted at 75 ° C for 48 h. After the completion of the reaction, the mixture was taken out, rinsed with deionized water, and dried at room temperature to obtain an aluminum sheet having a hydrotalcite film.
步骤 C:称取 0.15 g的三磷酸腺苷溶解于去离子水中配成 150 ml的三磷 酸腺苷溶液, 再用浓度为 1%的 ΝΗ3 · H20将三磷酸腺苷溶液的 pH调节为 6.5, 将步骤 B 中制备的长有水滑石薄膜的铝片垂直悬吊在上述反应合成液 中, 在 75°C下反应 48 h, 反应结束后用去离子水冲洗 5遍, 于室温下干燥, 得到三磷酸腺苷插层水滑石的薄膜。 由 X射线衍射图可知,采用原位生长法制备的三磷酸腺苷插层水滑石薄 膜, 其层板间距为 1.656 nm; 说明三磷酸腺苷成功进入水滑石膜层间。 从扫 描电镜的平面和截面照片中可以看出在该膜中, 水滑石层板为垂直于基底的 排列方式, 膜的厚度大约为 0.45 μηι。 实施例 3 Step C: Weigh 0.15 g of adenosine triphosphate dissolved in deionized water to prepare 150 ml of adenosine triphosphate solution, and adjust the pH of the adenosine triphosphate solution to 6.5 with a concentration of 1% ΝΗ 3 · H 2 0. The aluminum sheet with the hydrotalcite film is suspended vertically in the above reaction synthesis solution, and reacted at 75 ° C for 48 h. After the reaction, it is washed 5 times with deionized water and dried at room temperature to obtain adenosine triphosphate intercalated hydrotalcite. film. It can be seen from the X-ray diffraction pattern that the adenosine triphosphate intercalated hydrotalcite film prepared by in-situ growth method has a plate spacing of 1.656 nm; indicating that adenosine triphosphate successfully enters the hydrotalcite film layer. It can be seen from the plane and cross-sectional photographs of the scanning electron microscope that in the film, the hydrotalcite laminate is arranged perpendicular to the substrate, and the thickness of the film is about 0.45 μη. Example 3
步骤 Α: 按实施例 1中步骤 Α方法得到 AAO/A1基底。  Step Α: The AAO/A1 substrate was obtained by the procedure of Example 1 in Example 1.
步骤 B:分别称取 2.908 g的 Ni(N03)2 · 6H2O(0.01mol)和 4.8 g的 NH4N03 (0.06 mol)溶解于去离子水中配成 100 ml的反应合成液, 再用浓度为 1%的 ΝΗ3 · ¾0将反应合成液的 pH调节为 6.5。将步骤 A中制备的大小为 1 cmX 2 cm阳极氧化铝 /铝 (AAO/A1)基底垂直悬吊在上述反应合成液中,在 75°C下反 应 48 h。 反应结束后取出, 用去离子水冲洗后, 于室温下干燥, 得到长有水 滑石薄膜的铝片。 Step B: Weigh 2.908 g of Ni(N0 3 ) 2 · 6H 2 O (0.01 mol) and 4.8 g of NH 4 N0 3 (0.06 mol), respectively, in deionized water to prepare 100 ml of the reaction synthesis solution, and then The pH of the reaction mixture was adjusted to 6.5 with a concentration of 1% ΝΗ 3 · 3⁄40. The anodized aluminum/aluminum (AAO/A1) substrate having a size of 1 cm×2 cm prepared in the step A was vertically suspended in the above reaction synthesis solution, and reacted at 75 ° C for 48 hours. After the completion of the reaction, the mixture was taken out, rinsed with deionized water, and dried at room temperature to obtain an aluminum sheet having a hydrotalcite film.
步骤 C:称取 0.15 g的三磷酸腺苷溶解于去离子水中配成 150 ml的三磷 酸腺苷溶液, 再用浓度为 1%的 ΝΗ3 · H20将三磷酸腺苷溶液的 pH调节为 6.5, 将步骤 B制备的长有水滑石薄膜的铝片垂直悬吊在上述反应合成液中, 在 75°C下反应 48 h, 反应结束后用去离子水冲洗 5遍, 于室温下干燥, 得到 三磷酸腺苷插层水滑石的薄膜。 Step C: Weigh 0.15 g of adenosine triphosphate dissolved in deionized water to prepare 150 ml of adenosine triphosphate solution, and adjust the pH of the adenosine triphosphate solution to 6.5 with a concentration of 1% ΝΗ 3 · H 2 0. The aluminum sheet with hydrotalcite film is suspended vertically in the above reaction synthesis solution, and reacted at 75 ° C for 48 h. After the reaction, it is washed 5 times with deionized water and dried at room temperature to obtain a film of adenosine triphosphate intercalated hydrotalcite. .
由 X射线衍射图可知,采用原位生长法制备的三磷酸腺苷插层水滑石薄 膜, 其层板间距为 1.635 nm; 说明三磷酸腺苷成功进入水滑石膜层间。 从扫 描电镜的平面和截面照片中可以看出在该膜中,水滑石层板为垂直于基底的 排列方式, 膜的厚度大约为 0.45 μηι。  From the X-ray diffraction pattern, the adenosine triphosphate intercalated hydrotalcite film prepared by in-situ growth method has a plate spacing of 1.635 nm; indicating that adenosine triphosphate successfully enters the hydrotalcite film layer. It can be seen from the plane and cross-sectional photographs of the scanning electron microscope that in the film, the hydrotalcite laminate is arranged perpendicular to the substrate, and the thickness of the film is about 0.45 μη.

Claims

权利要求书 Claim
1. 一种三磷酸腺苷插层水滑石薄膜,其特征在于:该薄膜为超分子结构, 该薄膜的晶体结构为水滑石材料的晶体结构, 其化学式为: An adenosine triphosphate intercalated hydrotalcite film, characterized in that the film is a supramolecular structure, and the crystal structure of the film is a crystal structure of a hydrotalcite material, and the chemical formula is:
[(M2+) 1-x(M3+)x(OH )2]x+(ATP3-)x/3 - m¾0 , 其中, 0·2 χ 0·33 ; ATP3-表 示三磷酸腺苷的阴离子, m为层间结晶水分子数, 且 m=3-6。 [(M 2+ ) 1-x (M 3+ ) x (OH ) 2 ] x+ (ATP 3 -)x/3 - m3⁄40 , wherein 0·2 χ 0·33 ; ATP 3 - represents an anion of adenosine triphosphate, m is the number of crystal water molecules in the interlayer, and m = 3-6.
2. 根据权利要求 1所述的三磷酸腺苷插层水滑石薄膜,其特征在于:所 述 M2+为选自 Zn2+、 Mg2+、 Co2+、 Ni2+、 Ca2+、 Cu2+、 Fe2+和 Mn2+中的一种或 几种的二价金属阳离子, 所述 M3+为选自 Al3+、 Cr3+、 Ga3+、 In3+、 Co3+、 Fe3+ 和 V3+中的一种或几种的三价金属阳离子。 The adenosine triphosphate intercalated hydrotalcite film according to claim 1, wherein the M 2+ is selected from the group consisting of Zn 2+ , Mg 2+ , Co 2+ , Ni 2+ , Ca 2+ , Cu 2 . a divalent metal cation of one or more of + , Fe 2+ and Mn 2+ , wherein said M 3+ is selected from the group consisting of Al 3+ , Cr 3+ , Ga 3+ , In 3+ , Co 3+ , A trivalent metal cation of one or more of Fe 3+ and V 3+ .
3. 根据权利要求 2所述的三磷酸腺苷插层水滑石薄膜,其特征在于:所 述 M2+为 Zn2+、 Co2+或 Ni2+, 所述 M3+为 Al3+The adenosine triphosphate intercalated hydrotalcite film according to claim 2, wherein the M 2+ is Zn 2+ , Co 2+ or Ni 2+ , and the M 3+ is Al 3+ .
4. 一种三磷酸腺苷插层水滑石薄膜的制备方法,其特征在于,该制备方 法包括: A method for preparing an adenosine triphosphate intercalated hydrotalcite film, characterized in that the preparation method comprises:
a. 将铝片分别在无水乙醇和去离子水中超声清洗 2-10 min, 然后放入 NaOH溶液中处理 l-3 min,再用去离子水冲洗干净,将清洗后的铝片作为阳 极, 铅片作为阴极, 以¾804溶液作电解液, 在恒压下进行电解, 工作电压 15-25 V, 电流为 1.5-3 A, 电解时间为 0.5-2 h, 电解温度为室温, 从而在金 属铝的表面形成阳极氧化铝层,将得到的阳极氧化铝 /铝基底用去离子水清洗 干净, 在 25-90°C下干燥; a. The aluminum sheets are ultrasonically cleaned in absolute ethanol and deionized water for 2-10 min, then placed in NaOH solution for l-3 min, rinsed with deionized water, and the cleaned aluminum sheet is used as an anode. The lead piece is used as the cathode, and the 3⁄480 4 solution is used as the electrolyte. The electrolysis is carried out under constant pressure. The working voltage is 15-25 V, the current is 1.5-3 A, the electrolysis time is 0.5-2 h, and the electrolysis temperature is room temperature, thereby Anodized aluminum layer is formed on the surface of the aluminum, and the obtained anodized aluminum/aluminum substrate is washed with deionized water and dried at 25-90 ° C;
b. 分别称取可溶性二价金属盐和 NH4N03溶解于去离子水中配成反应 合成液, 再用氨水将反应合成液的 pH调节在 5.9-8.5之间, 将步骤 a所制备 的阳极氧化铝 /铝基底垂直悬吊在上述反应合成液中, 在 40-130°C温度下反 应 12-96 h, 反应结束后用去离子水冲洗 3-5遍, 于室温下干燥, 得到长有水 滑石薄膜的铝片; C. 将三磷酸腺苷溶解在水中制得三磷酸腺苷溶液,再用氨水将所述三磷 酸腺苷溶液的 pH值调节在 5.9-8.5之间,然后放入步骤 b中制备的长有水滑 石薄膜的铝片, 于 40-130°C温度下反应 12-96 h, 反应结束后将得到的产品 用去离子水冲洗 3-5遍,于室温下干燥,得到三磷酸腺苷插层水滑石的薄膜; 所述铝片、三磷酸腺苷和二价金属盐的用量使得到的三磷酸腺苷插层水 滑石的薄膜具有以下化学式: b. Weigh the soluble divalent metal salt and NH 4 N0 3 separately dissolved in deionized water to form a reaction synthesis liquid, and then adjust the pH of the reaction synthesis solution to 5.9-8.5 with ammonia water, and prepare the anode prepared in step a. The alumina/aluminum substrate is suspended vertically in the above reaction synthesis solution, and reacted at a temperature of 40-130 ° C for 12-96 h. After the reaction, rinse with deionized water for 3-5 times, and dry at room temperature to obtain a long Aluminum sheet of hydrotalcite film; C. Dissolving adenosine triphosphate in water to prepare adenosine triphosphate solution, and adjusting the pH of the adenosine triphosphate solution to between 5.9 and 8.5 with ammonia water, and then placing the aluminum sheet with hydrotalcite film prepared in step b, at 40 The reaction is carried out at a temperature of -130 ° C for 12-96 h. After the reaction is completed, the obtained product is washed with deionized water for 3-5 times, and dried at room temperature to obtain a film of adenosine triphosphate intercalated hydrotalcite; the aluminum sheet, adenosine triphosphate and The amount of the divalent metal salt is such that the film of the adenosine triphosphate intercalated hydrotalcite has the following chemical formula:
[(M2+)1-x(M3+)x(OH )2]X+(ATP3 )x/3-mH20, 其中, 0·2 χ 0·33 ; ATP3-表 示三磷酸腺苷的阴离子, m为层间结晶水分子数, 且 m=3-6。 [(M 2+ ) 1-x (M 3+ ) x (OH ) 2 ] X+ (ATP 3 ) x/3 -mH 2 0, wherein 0·2 χ 0·33 ; ATP 3 - represents an anion of adenosine triphosphate m is the number of crystal water molecules in the interlayer, and m = 3-6.
5. 根据权利要求 4所述的制备方法, 其中, 所述步骤 a中 NaOH的浓 度为 0.1-0.4 M, H2S04溶液的浓度为 1-2 M。 The preparation method according to claim 4, wherein the concentration of the NaOH in the step a is 0.1-0.4 M, and the concentration of the H 2 S0 4 solution is 1-2 M.
6. 根据权利要求 5所述的制备方法, 其中, 所述步骤 b中, 每 150 ml 的所述反应合成液所含的二价金属盐的物质的量为 0.01-0.06 mol, NH4N03 的物质的量为 0.01-0.06 mol; 氨水的质量分数为 1%-4%。 The preparation method according to claim 5, wherein, in the step b, the amount of the divalent metal salt contained in each of the 150 ml of the reaction synthetic liquid is 0.01-0.06 mol, NH 4 N0 3 The amount of the substance is 0.01-0.06 mol; the mass fraction of the ammonia water is 1%-4%.
7. 根据权利要求 4所述的制备方法, 其中,所述步骤 c中三磷酸腺苷溶 液的浓度为 1-2 g/L, 氨水的质量分数为 1%-4%。 The preparation method according to claim 4, wherein the concentration of the adenosine triphosphate solution in the step c is 1-2 g/L, and the mass fraction of the ammonia water is 1% to 4%.
8. 根据权利要求 4-7中任意一项所述的制备方法, 其中, 所述可溶性二 价金属盐中的二价金属阳离子为选自 Zn2+、 Mg2+、 Co2+、 Ni2+、 Ca2+、 Cu2+、 Fe2+和 Mn2+中的一种或几种。 The preparation method according to any one of claims 4 to 7, wherein the divalent metal cation in the soluble divalent metal salt is selected from the group consisting of Zn 2+ , Mg 2+ , Co 2+ , Ni 2 One or more of + , Ca 2+ , Cu 2+ , Fe 2+ and Mn 2+ .
9. 根据权利要求 8所述的制备方法,其中,所述可溶性二价金属盐中的 二价金属阳离子为 Zn2+、 Co2+或 Ni2+The production method according to claim 8, wherein the divalent metal cation in the soluble divalent metal salt is Zn 2+ , Co 2+ or Ni 2+ .
PCT/CN2009/072079 2009-03-18 2009-06-01 Adenosine triphosphate intercalated hydrotalcite film and preparation method therefor WO2010105454A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200910080440.1 2009-03-18
CN2009100804401A CN101530620B (en) 2009-03-18 2009-03-18 Adenosine triphosphate intercalation hydrotalcite film and preparation method thereof

Publications (1)

Publication Number Publication Date
WO2010105454A1 true WO2010105454A1 (en) 2010-09-23

Family

ID=41101617

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2009/072079 WO2010105454A1 (en) 2009-03-18 2009-06-01 Adenosine triphosphate intercalated hydrotalcite film and preparation method therefor

Country Status (2)

Country Link
CN (1) CN101530620B (en)
WO (1) WO2010105454A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112080263A (en) * 2020-09-21 2020-12-15 西南石油大学 Preparation method of slow-release retarder for well cementation

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103952720B (en) * 2014-04-29 2016-03-30 北京化工大学 Metal base/containing cobalt acrylic/hydrotalcite-like nano membrane electrode and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1507778A (en) * 2002-12-13 2004-06-30 北京化工大学 Supermolecular structure glyphosate slow release agent and preparing method thereof
US20070022916A1 (en) * 2005-08-01 2007-02-01 Laila Raki Controlled release of chemical admixtures
CN101285185A (en) * 2008-03-21 2008-10-15 北京化工大学 Preparation method of corrosion resistant hydrotalcite-like film at surface of aluminum and aluminum alloy parts

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100572600C (en) * 2008-07-11 2009-12-23 北京化工大学 Cyclodextrin intercalation hydrotalcite film of vertical substrate grown and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1507778A (en) * 2002-12-13 2004-06-30 北京化工大学 Supermolecular structure glyphosate slow release agent and preparing method thereof
US20070022916A1 (en) * 2005-08-01 2007-02-01 Laila Raki Controlled release of chemical admixtures
CN101285185A (en) * 2008-03-21 2008-10-15 北京化工大学 Preparation method of corrosion resistant hydrotalcite-like film at surface of aluminum and aluminum alloy parts

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HIROKI TAMURA ET AL.: "Formation of Hydrotalcite in Aqueous Solutions and Intercalation of ATP by Anion Exchange", JOURNAL OF COLLOID AND INTERFACE SCIENCE., vol. 300, no. 2, 4 May 2006 (2006-05-04), pages 648 - 654 *
TAMURA, H. ET AL.: "Synthesis and Characterization of Hydrotalcite-ATP Intercalates.", SOLID STATE IONICS., vol. 172, no. 1-4, 31 August 2004 (2004-08-31), pages 607 - 609, XP004612920, DOI: doi:10.1016/j.ssi.2004.04.035 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112080263A (en) * 2020-09-21 2020-12-15 西南石油大学 Preparation method of slow-release retarder for well cementation
CN112080263B (en) * 2020-09-21 2022-05-20 西南石油大学 Preparation method of slow-release retarder for well cementation

Also Published As

Publication number Publication date
CN101530620B (en) 2012-05-23
CN101530620A (en) 2009-09-16

Similar Documents

Publication Publication Date Title
WO2010003336A1 (en) A cyclodextrin intercalated hydrotalcite thin-film vertically grown on a substrate, and a method for producing the same
Jeon et al. Mussel-inspired green synthesis of silver nanoparticles on graphene oxide nanosheets for enhanced catalytic applications
CN105566654B (en) One-dimentional structure metal organic framework compound and preparation method thereof
CN102976278B (en) Laminar bimetal hydroxide and preparation method thereof
CN101245151B (en) Hydrotalcite/polyalcohol composite self-supporting thin film and manufacture method thereof
WO2007071130A1 (en) Vertically-orientated hydrotalcite-like film having composite micro-structure and its preparation method
Wang et al. Controlled drug release characteristics and enhanced antibacterial effect of graphene oxide–drug intercalated layered double hydroxide hybrid films
Xiao et al. Self-assembled 3D flower-like Ni2+–Fe3+ layered double hydroxides and their calcined products
Arai et al. Preparation of Co–Al layered double hydroxides by the hydrothermal urea method for controlled particle size
Wang et al. Preparation of 3D rose-like NiO complex structure and its electrochemical property
CN105622445B (en) A kind of method of the metal-organic framework materials of synthesis nano at room temperature
Karami et al. Epoxy/Zn-Al-CO3 LDH nanocomposites: curability assessment
WO2009036660A1 (en) A method for preparing film of layered double hydroxides
Xie et al. Recent Progress in 2D Metal‐Organic Framework‐Related Materials
Sun et al. Facile synthesis via a solvothermal route and characterization of Mg–Al layered double hydroxide (LDH) 3D micro–nano structures
Lv et al. A general strategy for the synthesis of layered double hydroxide nanoscrolls on arbitrary substrates: its formation and multifunction
Tavakoli et al. A facile synthesis of CuI-graphene nanocomposite by glucose as a green capping agent and reductant
CN101113012A (en) Highly-adherent super-hydrophobic double-functional intercalation configuration type hydrotalcite film and method for preparing same
Deng et al. A novel approach to Bi2Te3 nanorods by controlling oriented attachment
JP2009173482A (en) Swellable layered double hydroxide and its manufacturing method, and gel-like substance, sol-like substance and nanosheet using the same
Jeon et al. Structural evolution of NiAl-based layered nanostructures grown by a low-temperature hydrothermal method
WO2010105454A1 (en) Adenosine triphosphate intercalated hydrotalcite film and preparation method therefor
Kuramoto et al. Mechanochemical synthesis of finite particle of layered double hydroxide-acetate intercalation compound: Swelling, thin film and ion exchange
CN102674384B (en) Hydrotalcite like compound-kaolin composite material and preparation method thereof
CN112266485A (en) Universal two-dimensional rare earth MOFs material, solvent-free chemical stripping method and application thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09841737

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09841737

Country of ref document: EP

Kind code of ref document: A1